Vulnerability in Smiths-Medical Cadd-Solis Medication Safety Software
CVE-2016-8358
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints.
EPSS: 0.005 (39.9th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 8.5 (High). Vector: CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:H.
Affected products
- Smiths-medical Cadd-solis_medication_safety_software — versions 1.0, 2.0, 3.0
- N/a Smiths-medical Cadd-solis Medication Safety Software Through 3.1 — versions Smiths-Medical CADD-Solis Medication Safety Software through 3.1
Weakness classification (CWE)
References
- ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory, x_refsource_MISC)
- ics-cert@hq.dhs.gov (VDB Entry, Third Party Advisory, vdb-entry, x_refsource_BID)
Frequently asked questions
- What is CVE-2016-8358?
- CVE-2016-8358 is a high-severity vulnerability in Smiths-Medical Cadd-Solis Medication Safety Software, classified under Origin Validation Error. CVSS score: 8.5/10. Published 2017-02-13.
- How severe is CVE-2016-8358?
- High severity. CVSS v3 base score is 8.5 out of 10.